International Stem Cell Corporation Announces Third Patient with Parkinson’s Disease in Phase I Clinical Trial – GlobeNewswire (press release)
|
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial
GlobeNewswire (press release) CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced the … |
